Home » Philogen Partners With Janssen Biotech on Drug Development
Philogen Partners With Janssen Biotech on Drug Development
Biotech firm Philogen has entered into a collaboration and licensing agreement with Johnson & Johnson division Janssen Biotech, the two companies disclosed Wednesday.
The venture will focus on discovering and developing a new class of immunomodulatory therapeutics.
Neither company disclosed the terms of the deal.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May